Tocilizumab for severe COVID-19 pneumonia

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{dcaff3c4083b43488dfda02978457c3d,

title = "Tocilizumab for severe COVID-19 pneumonia",

author = "Lipworth, {Brian J} and Rory Chan and Kuo, {Chris Ruiwen}",

year = "2020",

month = nov,

doi = "10.1016/S2665-9913(20)30283-6",

language = "English",

volume = "2",

pages = "e660",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier",

number = "11",

}

TY - JOUR

T1 - Tocilizumab for severe COVID-19 pneumonia

AU - Lipworth, Brian J

AU - Chan, Rory

AU - Kuo, Chris Ruiwen

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85090019945&partnerID=8YFLogxK

U2 - 10.1016/S2665-9913(20)30283-6

DO - 10.1016/S2665-9913(20)30283-6

M3 - Letter

C2 - 32838325

SN - 2665-9913

VL - 2

SP - e660

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 11

ER -